Open AccessPlasma Urate and Progression of Mild Cognitive Impairment
Author(s) -
Michael C. Irizarry,
Rema Raman,
Michael A. Schwarzschild,
Lida M. Becerra,
Ronald G. Thomas,
Ronald C. Peterson,
Alberto Ascherio,
Paul Aisen
Publication year - 2008
Publication title -
neurodegenerative diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.98
H-Index - 57
eISSN - 1660-2862
pISSN - 1660-2854
DOI - 10.1159/000170883
Subject(s) - donepezil , placebo , uric acid , medicine , cognitive decline , alzheimer's disease , endocrinology , cognition , psychology , dementia , disease , pathology , psychiatry , alternative medicine
Impaired antioxidant defenses are implicated in neurodegenerative disease. The plasma levels of urate, a water-soluble antioxidant, are reduced in Alzheimer's disease (AD).
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom